Last reviewed · How we verify
exhaled breath collection
At a glance
| Generic name | exhaled breath collection |
|---|---|
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Caracterization of the Combined Alterations in Respiration and aROUSal in Patients With Drug-resistant EpiLepsy (NA)
- Optimization of Exhaled Biomarker Collection and Analysis (NA)
- Gut Microbiome-Metabolome Profiling in H. Pylori-SIBO Comorbidity
- Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma
- Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma (VAPOR2)
- Sample Collections From the Airways of Asthmatic Patients
- Omic Technologies to Track Resistance to Palbociclib in Metastatic Breast Cancer (NA)
- Feasibility of Breathwork Intervention With Older Adults After Knee Surgery (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- exhaled breath collection CI brief — competitive landscape report
- exhaled breath collection updates RSS · CI watch RSS
- Assistance Publique - Hôpitaux de Paris portfolio CI